Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 1.47% is 72% below its 5-year average of 5.21%, around the middle of its 5-year range (-11.48%–17.20%).
54.55% below its 12-month average of 3.23%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.36%.
EBITDA MARGIN
1.47%
EBITDA MARGIN AVG TTM
3.23%
EBITDA MARGIN AVG 3Y
1.43%
EBITDA MARGIN AVG 5Y
5.21%
EBITDA MARGIN AVG 10Y
6.10%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-54.55%
CURRENT VS 3Y AVG
+2.45%
CURRENT VS 5Y AVG
-71.76%
CURRENT VS 10Y AVG
-75.92%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$104.81M
EBITDA Margin
6.31%
TTM Avg
-127.53%
3Y Avg
-89.97%
5Y Avg
-50.55%
Market Cap
$98.84M
EBITDA Margin
-5221.43%
TTM Avg
-5221.43%
3Y Avg
-3887.65%
5Y Avg
-3386.47%
Market Cap
$106.13M
EBITDA Margin
-6164.17%
TTM Avg
-4620.17%
3Y Avg
-2654.54%
5Y Avg
-2163.85%
Market Cap
$106.38M
EBITDA Margin
5.60%
TTM Avg
2.28%
3Y Avg
0.00%
5Y Avg
-2.15%
Market Cap
$96.05M
EBITDA Margin
-1299.47%
TTM Avg
-2594.80%
3Y Avg
-2594.80%
5Y Avg
-1753.28%
Market Cap
$109.49M
EBITDA Margin
-10.96%
TTM Avg
-24.45%
3Y Avg
-32.87%
5Y Avg
-38.11%
Market Cap
$98.00M
EBITDA Margin
-4034.35%
TTM Avg
-4034.35%
3Y Avg
-3775.34%
5Y Avg
-2903.14%
Market Cap
$107.84M
EBITDA Margin
-29.32%
TTM Avg
-13.32%
3Y Avg
-6.17%
5Y Avg
-1.07%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Joint Corp. (JYNT) | $102.35M | 1.47% | 3.23% | 1.43% | 5.21% |
| Definitive Healthcare Corp. (DH)vs › | $104.81M | 6.31% | -127.53% | -89.97% | -50.55% |
| Anixa Biosciences, Inc. (ANIX)vs › | $98.84M | -5221.43% | -5221.43% | -3887.65% | -3386.47% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.13M | -6164.17% | -4620.17% | -2654.54% | -2163.85% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.38M | 5.60% | 2.28% | 0.00% | -2.15% |
| Korro Bio, Inc. (KRRO)vs › | $96.05M | -1299.47% | -2594.80% | -2594.80% | -1753.28% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -10.96% | -24.45% | -32.87% | -38.11% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $98.00M | -4034.35% | -4034.35% | -3775.34% | -2903.14% |
| BGM Group Ltd. (BGM)vs › | $107.84M | -29.32% | -13.32% | -6.17% | -1.07% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.59M | 28.85% | 28.85% | 28.85% | 28.85% |
Gross Margin
81.1%
EBITDA Margin
1.5%
Operating Margin
2.5%
Net Margin
6.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 0.36% |
| 2026-03-31 | 8.74% |
| 2025-12-31 | 7.83% |
| 2025-09-30 | 4.66% |
| 2025-06-30 | -5.42% |
| 2025-03-31 | -2.22% |
| 2024-12-31 | -11.48% |
| 2024-09-30 | -6.45% |
| 2024-06-30 | -2.03% |
| 2024-03-31 | 8.02% |
| 2023-12-31 | 5.03% |
| 2023-09-30 | 4.92% |
| 2023-06-30 | 6.67% |
| 2023-03-31 | 5.52% |
| 2022-12-31 | 12.88% |
| 2022-09-30 | 9.50% |
| 2022-06-30 | 0.53% |
| 2022-03-31 | 5.84% |
| 2021-12-31 | 8.24% |
| 2021-09-30 | 14.30% |
| 2021-06-30 | 17.20% |
| 2021-03-31 | 17.90% |
| 2020-12-31 | 20.23% |
| 2020-09-30 | 15.70% |
| 2020-06-30 | 7.56% |
| 2020-03-31 | 10.32% |
| 2019-12-31 | 13.94% |
| 2019-09-30 | 9.26% |
| 2019-06-30 | 7.99% |
| 2019-03-31 | 13.25% |
| 2018-12-31 | 14.45% |
| 2018-09-30 | 2.46% |
| 2018-06-30 | 4.03% |
| 2018-03-31 | -0.73% |
| 2017-12-31 | 3.49% |
| 2017-09-30 | 1.39% |
| 2017-06-30 | -8.00% |
| 2017-03-31 | -17.78% |
| 2016-12-31 | -87.77% |
| 2016-09-30 | -34.87% |
| 2016-06-30 | -51.34% |
| 2016-03-31 | -68.23% |
| 2015-12-31 | -81.26% |
| 2015-09-30 | -39.38% |
| 2015-06-30 | -45.74% |
| 2015-03-31 | -71.48% |
| 2014-12-31 | -42.24% |
| 2014-09-30 | -14.20% |
| 2014-06-30 | -9.26% |
| 2014-03-31 | -7.76% |
| 2013-12-31 | 9.77% |
| 2013-09-30 | 14.45% |
